Page 18 - Zai Lab News Today

$329 million in third quarter global net product salesOn track to submit VYVGART® Hytrulo sBLA for CIDP by year-end 2023 Results from the ADVANCE-IV study published in The Lancet Management to host conference call

WALTHAM, Mass., October 30, 2023--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced financial results for the third quarter ended September 30, 2023 and provided a corporate update.

AI is predicted to help businesses increase profits, but not all local businesses can yet afford to develop and apply it, according to industry experts.

SHANGHAI, China and CAMBRIDGE, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)) today announced that members of the Company's senior management team will participate in the following

Generative AI applications have huge potential to revolutionise working practices across public and private sectors across Vietnam, according to a Google conference held last week.

Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So spare a thought for...

The International Society of Engineering Asset Management’s Outstanding Achievement Award recognises the contribution to digital transformation efforts of Denis Brunetti.

1

Analyst David Li of Bank of America Securities maintained a Buy rating on Zai Lab (ZLAB – Research Report), with a price target of $35.38....

- Company to Host Conference Call and Webcast on November 8, 2023, at 8:00 a.m. ETSHANGHAI, China and CAMBRIDGE, Mass., Oct. 18, 2023 -- Zai Lab Limited today announced that it will report...